Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 21 of 86 for:    NIDDK endocrine and diabetes | Recruiting, Not yet recruiting, Available Studies

Rituximab and Abatacept for Prevention or Reversal of Type 1 Diabetes (TN25)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03929601
Recruitment Status : Not yet recruiting
First Posted : April 29, 2019
Last Update Posted : August 15, 2019
National Institutes of Health (NIH)
Juvenile Diabetes Research Foundation
Information provided by (Responsible Party):
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 2025
Estimated Study Completion Date : July 2026